Patient information seminars in Stockholm (11.9.2018) and in Helsinki (4.10.2018)

The Chemical Industry Federation of Finland’s Innovation Award to the Team of the Institute of Biotechnology and Herantis Pharma

Herantis Pharma opening recruitment in Parkinson’s disease study in Helsinki and Lund based on favorable first CDNF safety assessment

Parkinson’s prevalence expected to increase by 18% by 2025